AB103 vs placebo
SAEs · NSTI
It is very uncertain whether AB103 changes serious adverse events (SAE) compared with placebo (very low certainty).
1 finding from 1 review
- Interventions for necrotizing soft tissue infections in adults 2018 · Cochrane Headline outcomes onlyRR 1.49 [0.52, 4.27]1 study · 43 participantsVery low